Cargando…
Pre-clinical development of T-cell immunotherapy for covid-19
Autores principales: | Smith, C., Panikkar, A., Raju, J., Rehan, S., Lineburg, K., Crooks, P., Ambalathingal Thomas, G., Swaminathan, S., Khanna, R., Matthews, K., Neller, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111906/ http://dx.doi.org/10.1016/S1465324921004424 |
Ejemplares similares
-
Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases
por: Lineburg, Katie E, et al.
Publicado: (2020) -
Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine
por: Lineburg, Katie E, et al.
Publicado: (2021) -
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
por: Panikkar, Archana, et al.
Publicado: (2022) -
Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
por: Henden, A., et al.
Publicado: (2023) -
Ablation of CD8(+) T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3
por: Swaminathan, Srividhya, et al.
Publicado: (2022)